These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27774731)

  • 1. Impact of phosphoproteomics in the translation of kinase-targeted therapies.
    Casado P; Hijazi M; Britton D; Cutillas PR
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 27774731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine.
    Wu X; Xing X; Dowlut D; Zeng Y; Liu J; Liu X
    J Proteomics; 2019 Jan; 191():68-79. PubMed ID: 29621648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
    Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
    EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?
    Gruber W; Scheidt T; Aberger F; Huber CG
    Cell Commun Signal; 2017 Mar; 15(1):12. PubMed ID: 28356110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive-unlabeled ensemble learning for kinase substrate prediction from dynamic phosphoproteomics data.
    Yang P; Humphrey SJ; James DE; Yang YH; Jothi R
    Bioinformatics; 2016 Jan; 32(2):252-9. PubMed ID: 26395771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance.
    Alcolea MP; Casado P; Rodríguez-Prados JC; Vanhaesebroeck B; Cutillas PR
    Mol Cell Proteomics; 2012 Aug; 11(8):453-66. PubMed ID: 22547687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of phosphoproteomics and applications in cancer research.
    Higgins L; Gerdes H; Cutillas PR
    Biochem J; 2023 Mar; 480(6):403-420. PubMed ID: 36961757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illuminating the dark phosphoproteome.
    Needham EJ; Parker BL; Burykin T; James DE; Humphrey SJ
    Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoproteomics Meets Chemical Genetics: Approaches for Global Mapping and Deciphering the Phosphoproteome.
    Jurcik J; Sivakova B; Cipakova I; Selicky T; Stupenova E; Jurcik M; Osadska M; Barath P; Cipak L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KinasePA: Phosphoproteomics data annotation using hypothesis driven kinase perturbation analysis.
    Yang P; Patrick E; Humphrey SJ; Ghazanfar S; James DE; Jothi R; Yang JY
    Proteomics; 2016 Jul; 16(13):1868-71. PubMed ID: 27145998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target.
    Yángüez E; Hunziker A; Dobay MP; Yildiz S; Schading S; Elshina E; Karakus U; Gehrig P; Grossmann J; Dijkman R; Schmolke M; Stertz S
    Nat Commun; 2018 Sep; 9(1):3679. PubMed ID: 30206219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomic Approaches for Identifying Phosphatase and Kinase Substrates.
    DeMarco AG; Hall MC
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of conventional quantitative and phospho-proteomics reveals new elements in activated Jurkat T-cell receptor pathway maintenance.
    Jouy F; Müller SA; Wagner J; Otto W; von Bergen M; Tomm JM
    Proteomics; 2015 Jan; 15(1):25-33. PubMed ID: 25348772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of the art of quantitative phosphoproteomics and its applications to diabetes research.
    Chan CY; Gritsenko MA; Smith RD; Qian WJ
    Expert Rev Proteomics; 2016; 13(4):421-33. PubMed ID: 26960075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalization of prostate cancer therapy through phosphoproteomics.
    Yang W; Freeman MR; Kyprianou N
    Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.
    Francavilla C; Lupia M; Tsafou K; Villa A; Kowalczyk K; Rakownikow Jersie-Christensen R; Bertalot G; Confalonieri S; Brunak S; Jensen LJ; Cavallaro U; Olsen JV
    Cell Rep; 2017 Mar; 18(13):3242-3256. PubMed ID: 28355574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens.
    Abe Y; Hirano H; Shoji H; Tada A; Isoyama J; Kakudo A; Gunji D; Honda K; Boku N; Adachi J; Tomonaga T
    Theranostics; 2020; 10(5):2115-2129. PubMed ID: 32089736
    [No Abstract]   [Full Text] [Related]  

  • 18. A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis.
    Lee PY; Yeoh Y; Low TY
    FEBS J; 2023 Jun; 290(11):2845-2864. PubMed ID: 35313089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of phosphoproteomics in the development of personalized cancer therapies.
    Cutillas PR
    Proteomics Clin Appl; 2015 Apr; 9(3-4):383-95. PubMed ID: 25488289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases.
    Selvan LDN; Danda R; Madugundu AK; Puttamallesh VN; Sathe GJ; Krishnan UM; Khetan V; Rishi P; Prasad TSK; Pandey A; Krishnakumar S; Gowda H; Elchuri SV
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.